product name: dapagliflozin
cas: 461432-26-8
mf: c21h25clo6
grade: medical grade
assay: 99%
appearance: white powder
packing: 1kg/ aluminum foil bag can be split
ingredients: (1s) -1,5-, dehydration, -1-c-[4-, chlorine, -3-[(4- ethoxy phenyl) methyl] phenyl]-d-, glucose alcohol
category: pharmaceutical raw materials
industry: medicine
areas: antidiabetic drugs
use: used alone or in combination with metformin, glimepiride, pioglitazone, insulin and other drugs can be significantly reduced in patients with type 2 diabetes mellitus hba1c and fasting blood glucose, the incidence of adverse reactions similar to placebo, low risk of hypoglycemia, can reduce weight.
dapagliflozin (trade name farxiga far-see-g in the u.s. and forxiga in the eu and russia) is a drug of the gliflozin class, used to treat type 2 diabetes. it was developed by bristol-myers squibb in partnership with astrazeneca.